Timothy J. Guzi

2.7k total citations
31 papers, 1.4k citations indexed

About

Timothy J. Guzi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Timothy J. Guzi has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Timothy J. Guzi's work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (7 papers) and Fibroblast Growth Factor Research (4 papers). Timothy J. Guzi is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (7 papers) and Fibroblast Growth Factor Research (4 papers). Timothy J. Guzi collaborates with scholars based in United States, Ireland and United Kingdom. Timothy J. Guzi's co-authors include David Parry, Michael P. Dwyer, Wolfgang Seghezzi, Kamil Paruch, Derek Wiswell, Thierry Fischmann, Nicole R. Davis, Fergus Shanahan, Ronald J. Doll and Emma Lees and has published in prestigious journals such as Blood, Cancer Research and Journal of Hepatology.

In The Last Decade

Timothy J. Guzi

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy J. Guzi United States 16 792 538 261 258 160 31 1.4k
Lian‐Sheng Li United States 19 1.4k 1.7× 557 1.0× 314 1.2× 241 0.9× 127 0.8× 49 1.9k
Vito Guagnano Switzerland 16 896 1.1× 380 0.7× 343 1.3× 135 0.5× 112 0.7× 30 1.4k
Michael Zinda United States 22 935 1.2× 469 0.9× 128 0.5× 192 0.7× 123 0.8× 37 1.4k
Jeffrey H. Chen United States 6 1.0k 1.3× 520 1.0× 361 1.4× 353 1.4× 66 0.4× 7 1.6k
Derek Wiswell United States 11 522 0.7× 459 0.9× 151 0.6× 202 0.8× 132 0.8× 14 934
Peter Drueckes Switzerland 15 727 0.9× 290 0.5× 173 0.7× 146 0.6× 86 0.5× 24 1.2k
Y.N. Vashisht Gopal United States 18 1.2k 1.6× 872 1.6× 243 0.9× 261 1.0× 73 0.5× 25 1.8k
Kate F. Byth United States 15 520 0.7× 400 0.7× 228 0.9× 98 0.4× 281 1.8× 20 1.0k
Nathan T. Ihle United States 15 1.2k 1.5× 352 0.7× 184 0.7× 234 0.9× 68 0.4× 23 1.5k
Lily L. Remsing Rix United States 19 902 1.1× 429 0.8× 260 1.0× 179 0.7× 106 0.7× 28 1.8k

Countries citing papers authored by Timothy J. Guzi

Since Specialization
Citations

This map shows the geographic impact of Timothy J. Guzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy J. Guzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy J. Guzi more than expected).

Fields of papers citing papers by Timothy J. Guzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy J. Guzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy J. Guzi. The network helps show where Timothy J. Guzi may publish in the future.

Co-authorship network of co-authors of Timothy J. Guzi

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy J. Guzi. A scholar is included among the top collaborators of Timothy J. Guzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy J. Guzi. Timothy J. Guzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tubbs, Anthony, Javad Golji, Meredeth A. McGowan, et al.. (2025). Abstract 4205: Direct measurement of TA repeat expansions significantly outperforms MSI-H status as a predictor of sensitivity to the novel WRN inhibitor MOMA-341. Cancer Research. 85(8_Supplement_1). 4205–4205. 2 indexed citations
2.
Guzi, Timothy J., et al.. (2025). Human polymerase θ helicase positions DNA microhomologies for double-strand break repair. Nature Structural & Molecular Biology. 32(6). 1061–1068. 3 indexed citations
3.
Labroli, Marc, et al.. (2016). A convergent preparation of the CHK1 inhibitor MK-8776 (SCH 900776). Tetrahedron Letters. 57(24). 2601–2603. 4 indexed citations
4.
Rahal, Rami, Erica N Evans, Wei Hu, et al.. (2016). Abstract 2641: The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi-kinase inhibitors. Cancer Research. 76(14_Supplement). 2641–2641. 10 indexed citations
5.
Hagel, Margit, Chandra Miduturu, Michael P. Sheets, et al.. (2015). First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway. Cancer Discovery. 5(4). 424–437. 247 indexed citations
6.
Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2014). The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors. Bioorganic & Medicinal Chemistry. 22(7). 2303–2310. 10 indexed citations
7.
Labroli, Marc, Michael P. Dwyer, Ruichao Shen, et al.. (2013). Syntheses of 5′-amino-2′,5′-dideoxy-2′,2′-difluorocytidine derivatives as novel anticancer nucleoside analogs. Tetrahedron Letters. 55(3). 598–602. 5 indexed citations
8.
Guzi, Timothy J., Kamil Paruch, Michael P. Dwyer, et al.. (2011). Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening. Molecular Cancer Therapeutics. 10(4). 591–602. 135 indexed citations
9.
Parry, David, Timothy J. Guzi, Fergus Shanahan, et al.. (2010). Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor. Molecular Cancer Therapeutics. 9(8). 2344–2353. 434 indexed citations
10.
Taricani, Lorena, et al.. (2010). Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase . Cell Cycle. 9(24). 4876–4883. 20 indexed citations
11.
Dwyer, Michael P., Kamil Paruch, Marc Labroli, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 1. Bioorganic & Medicinal Chemistry Letters. 21(1). 467–470. 55 indexed citations
12.
Labroli, Marc, Kamil Paruch, Michael P. Dwyer, et al.. (2010). Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach—Part 2. Bioorganic & Medicinal Chemistry Letters. 21(1). 471–474. 62 indexed citations
13.
Zhao, Lianyun, Yingxin Zhang, Chaoyang Dai, et al.. (2010). Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7216–7221. 34 indexed citations
14.
Parry, David, Timothy J. Guzi, Wolfgang Seghezzi, et al.. (2007). In vitro and in vivo characterization of SCH727965 a novel potent cyclin dependent kinase inhibitor. Cancer Research. 67. 4371–4371. 3 indexed citations
15.
Dwyer, Michael P., Kamil Paruch, Carmen Álvarez, et al.. (2007). Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6216–6219. 29 indexed citations
16.
Fischmann, Thierry, Alan Hruza, José S. Duca, et al.. (2007). Structure‐guided discovery of cyclin‐dependent kinase inhibitors. Biopolymers. 89(5). 372–379. 46 indexed citations
17.
Guzi, Timothy J.. (2004). CYC-202 Cyclacel.. PubMed. 5(12). 1311–8. 21 indexed citations
18.
Chao, Jianping, et al.. (2002). Synthesis of substituted 1H-imidazol-1-ylmethylpiperidines. Facile separation of 1,4- and 1,5-disubstituted imidazoles. Tetrahedron Letters. 43(49). 8917–8919. 2 indexed citations
19.
Afonso, Adriano, Jay Weinstein, Joseph Kelly, et al.. (1999). Analogues of 1-(3,10-Dibromo-8-chloro-6,11-dihydro-5 H -benzo[5,6]-cyclohepta[1,2- b ]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase. Bioorganic & Medicinal Chemistry. 7(9). 1845–1855. 8 indexed citations
20.
Guzi, Timothy J. & Timothy L. Macdonald. (1996). A novel synthesis of piperidin-3-ones via an intramolecular Amadori-type reaction. Tetrahedron Letters. 37(17). 2939–2942. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lian‐Sheng Li Breakdown of academic impact, for papers by Vito Guagnano Breakdown of academic impact, for papers by Michael Zinda Breakdown of academic impact, for papers by Jeffrey H. Chen Breakdown of academic impact, for papers by Derek Wiswell Breakdown of academic impact, for papers by Peter Drueckes Breakdown of academic impact, for papers by Y.N. Vashisht Gopal Breakdown of academic impact, for papers by Kate F. Byth Breakdown of academic impact, for papers by Nathan T. Ihle Breakdown of academic impact, for papers by Lily L. Remsing Rix
Rankless by CCL
2026